In addition, we comprehensively discussed the effects of VT and RT on outcomes related to sarcopenia, including anthropometric measurements (BH, BW, and CC), muscle mass (SMM, SMI, ASM, and ASMI), muscle strength (HGS and KES), physical performance (TUG test, GS, and SPPB), blood biomarkers [hs-CRP, TNF-α, IL-6, IGF-1, GH, testosterone, 25(OH)D, MSTN, FST, and CK], and quality of life (SF-36), between two intervention groups and a control group. The gene discussed is TNF; the disease is sarcopenia.